Tag Archives: PTIE

Top Undervalued Stocks For 2018

Gazprom’s (OTCPK:OGZPY) (OTCQX:GZPFY) P/E ratio of 2.8 makes it worth a look to investors, and with a market cap of $45 billion and $180 billion in book value, which means that it owns $180 billion of it’s own immense pipeline and refining system and huge natural gas reserves. So to look at whether Gazprom is undervalued we must determine how sturdy those natural gas assets will be in the future.

To be long Gazprom, you have to be long natural gas, which requires a look at the supply and demand that makes up the pricing of natural gas around the world. Natural gas in the future in my view, will continually see demand increases throughout the world, as the continual increase in electrical vehicles will require a big switch-over from oil to natural gas, as power plants which are most economical as gas powered, are needed to power electricity and heating to homes although this trend will be a slow developing trend. And yet the supply part is not quite as bullish but still good for the long term prices for natural gas, as the advent of liquified natural gas, which is when natural gas is super cooled and shrunk down to hold more volume, has been increasing in recent years.

Top Undervalued Stocks For 2018: Pretium Resources, Inc.(PVG)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Pretium Resources (PVG) remains on target with its development of what will be a world-class gold mine in British Columbia. The Brucejack property is slated to begin commercial production in mid-2017.

Top Undervalued Stocks For 2018: SPDR S&P Bank ETF (KBE)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The market clearly likes the rate hike today. The S&P 500 has gained 1% to2,388.03 at 3:01 p.m. today. The Financial Select Sector SPDR ETF (XLF) has is little changed at $24.78, while the SPDR S&P Bank ETF (KBE) has dropped 0.7% to $44.59.

  • [By Ben Levisohn]

    Heck, it might just be easier to buy the lot, especially if you think earnings will be awesome. There’s an ETF for that you know (the SPDR S&P Bank ETF (KBE))?

  • [By Ben Levisohn]

    Shares of Bank of America have tumbled 4.7% to $23.30 at 11:30 a.m. today, Morgan Stanley has fallen 3.4% to $43.06, Goldman Sachs has declined 2.6% to $235.95, and Leucadia National is off 1.6% to $25.86. The SPDR S&P Bank ETF (KBE) has dropped 3.9% to $42.23.

  • [By Ben Levisohn]

    Shares of Citigroup have surged 1.2% to $56.48 at 11:09 a.m. today, while JPMorgan Chase has risen 1.2% to $85.67, Wells Fargo has advanced 0.5% to $56.22, and Bank of America has climbed 1.9% to $23.08. The SPDR S&P Bank ETF (KBE) is up 0.8% at $43.80.

  • [By Ben Levisohn]

    Shares of Wells Fargo have dropped 2.2% to $52.08 at 2:17 p.m. today, while the SPDR S&P Bank ETF (KBE) has risen 0.1% to $40.05, and the Financial Select Sector SPDR ETF (XLF) has fallen 0.7% to $22.06.

Top Undervalued Stocks For 2018: Pain Therapeutics(PTIE)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

Top Undervalued Stocks For 2018: Liberty Interactive Corporation(QVCA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    QVC (QVCA) was upgraded to buy from neutral at Bank of America/Merrill Lynch. $25 price target. The company can turn its sales around and deserves a higher multiple, analysts said. 

Top Undervalued Stocks For 2018: Statoil ASA(STO)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    NORW reflects Norway's oil exposure. The ETF allocates nearly 28.8 percent of its weight to the energy, 870 basis points more than it devotes to its second-largest sector exposure, financial services. State-run Statoil ASA(ADR) (NYSE: STO) is NORW's largest individual holding at a weight of 15.3 percent, or 560 basis points more than NORW allocates to its second-largest holding.

  • [By Ben Levisohn]

    Should oil prices recover, we believe that deepwater drilling activity growth should lag growth in US shale activity, as project economics is generally better in US shales, and E&Ps involved in US shales are generally quicker to react. Deepwater activity is largely comprises a handful of companies (Petrobras (PBR), Statoil (STO), Total (TOT), Shell (RDS.A), BP (BP), ONGC, ExxonMobil (XOM) and Chevron (CVX)) and it is unlikely that these companies can meaningfully increase their rig demand in a short period of time to absorb the current oversupply. Thus, should oil prices rise in 2018, rig demand may increase, but likely not enough to tighten the market, given that supply equaling 43% of current working rig count is stacked and new supply equaling 25% of working rig count is under-construction and should be entering the market in the coming years. As a result, while we expect some improvement in rig utilization owing to rig retirements, it will unlikely be strong enough to meaningfully improve rates in 2018 above spot levels. Any demand increase in the interim could slow rig retirements materially, and be self-defeating. We thus are Sell rated on Transocean, Atwood and Noble.

  • [By Paul Ausick]

    Norway’s Statoil ASA (NYSE: STO) announced this morning that it has acquired stakes in two North Sea projects from France’s Total S.A. (NYSE: TOT). The transaction, valued at $1.45 billion, includes a 51% equity stake in the Martin Linge field and a 40% stake in the Garantiana discovery, both located on Norway’s continental shelf.

  • [By Ben Levisohn]

    We believe that the equity market has neutralised much of its underweight energy positioning in 4Q/1Q, but was caught by the sharp rally in crude from end-January. Our base-case sees oil prices still higher by end-2016 (we see >$50/bbl), albeit with a choppy 2Q likely ahead. In this scenario a modest, rather than fully-fledged price-recovery we continue to place a lot of importance on self-help in driving ROE expansion (as opposed to relying simply on oil-leverage). Value-adjusted, we like the self-help stories around Total, Chevron, Statoil (STO), Royal Dutch Shell and Eni (E) in the group. Total is on the Citi European Focus list.

  • [By Cameron Swinehart]

    Going forward I will be looking to add investments on my watchlist and trim other positions. It will be interesting to see how an overweight commodity portfolio will perform relative to the rest of the market.

     Cost Basis# SharesCurrent Price% of PortfolioCurrent ValueReturnMetal/Miners      Sprott Physical Gold Trust (PHYS)$12.4985$11.043.75%$938.40-13.13%Sprott Physical Silver Trust (PSLV)$7.95125$8.744.37%$1,092.509.04%FreePort-McMoran (FCX)$31.6731$33.874.20%$1,049.976.50%Ishares MSCI Global Gold Miners ETF (RING)$13.0695$10.644.04%$1,010.80-22.74%Energy      Statoil ASA(STO)$21.7940$22.683.63%$907.203.92%Vanguard Natural Resources LLC (VNR)$27.5636$27.874.01%$1,003.321.11%ConocoPhillips (COP)$63.6822.43$71.006.37%$1,592.5310.31%Agriculture      CVR Partner LP (UAN)$26.3630.9$18.932.34%$584.94-39.25%Adecoagro$6.78125$7.443.72%$930.008.87%Archer-Daniels Midland (ADM)$34.8030$37.244.47%$1,117.206.55%Mixed Commodity      Powershares DB Commodity Index (DBC)$26.3540$25.954.15%$1,038.00-1.54%Sprott Resource Corp$3.34400$2.714.34%$1,084.00-23.25%    Total % of portfolio49.40%               Cost Basis12,666.00      Current Value12,348.86      Return-2.50%  Source: Investing For The Future Surge In Commodity Prices

    Disclosure: I am long ADM, FCX, UAN, AGRO, RING, VNR, SCPZF.PK, COP, DBC, PHYS, PSLV. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More…)

  • [By Jayson Derrick]

    BP plc (ADR) (NYSE: BP), Royal Dutch Shell plc (ADR) (NYSE: RDS-A) (NYSE: RDS-B) and Statoil ASA(ADR) (NYSE: STO) are expected to outperform their peers by offering: 1) the greatest rate of change in cost reduction through technology and innovation, 2) upstream portfolios with an attractive risk to reward profile and 3) sufficient liquidity to invest in future growth.

Top High Tech Stocks To Own Right Now

Sindre Lundvold/Barcroft Media

Theres no doubt health savings accounts are growing fast in the U.S., but are the people who own those accounts fully aware of their benefitsand pitfalls?

Top High Tech Stocks To Own Right Now: Pain Therapeutics(PTIE)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

Top High Tech Stocks To Own Right Now: Virtusa Corporation(VRTU)

Advisors’ Opinion:

  • [By Lisa Levin]

    Technology shares gained around 0.85 percent in trading on Friday. Meanwhile, top gainers in the sector included Virtusa Corporation (NASDAQ: VRTU), and Ceragon Networks Ltd (NASDAQ: CRNT).

Top High Tech Stocks To Own Right Now: TeleNav Inc.(TNAV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Telenav Inc (NASDAQ: TNAV) shares were also up, gaining 16 percent to $8.15 after the company reported the settlement of patent lawsuit. The company projects Q2 revenue of $51 million to $52 million and loss of $0.30 per share to $0.28 per share.

Top 10 Blue Chip Stocks To Buy Right Now

I will get right to it. After describing the reasons behind its meteoric rise and the discussing why this name was one of my top blue chip top picks for 2017, it comes down to performance. Just this morning Bank of America (NYSE:BAC), as well as other large banks, are out with key earnings reports. This matters for the 2017 call and it matters for the share price which has skyrocketed in the last few months. It’s about the performance. Performance not just on the top and bottom lines but also in several key metrics that I follow closely for all major banks. The bank has come a long way from it facing extinction, and it took we the people to keep it alive. Today Bank of America is one of the largest banks in the United States by assets and yes, it has recovered from the Great Recession. Is it firing on all cylinders like it was pre-recession? No, unfortunately it is not, but it is getting there. Can you stick with the name? We need to examine the company’s most recent earnings and key metrics to make that determination.

Top 10 Blue Chip Stocks To Buy Right Now: MFRI Inc.(MFRI)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggestedsmall cap piping systems stock MFRI, Inc (NASDAQ: MFRI) as a short-term long/bullish trade:

Top 10 Blue Chip Stocks To Buy Right Now: Wal-Mart Stores, Inc.(WMT)

Advisors’ Opinion:

  • [By Kumar Abhishek]

    China has a growing middle class and affluent consumers who have strong aspirational demand for western luxury goods. Last year Chinese tourists spent $183 billionon shopping sprees abroad, a good deal of them for buying luxury goods. According to a report on Mintel.com, 58% of the Chinese consumers have boughtforeign goods from local online eCommerce sites. Alibaba has used this trend to build its TmallGlobal. In the just concluded Singles’ day sale, thousands of foreign brands including Walmart (NYSE:WMT) and Apple (NSDQ:AAPL) had participated. A retaliatory tax increase by China on foreign goods will impact the sale of foreign goods. The sale of foreign brands is expected to produce around $2 billion in incremental revenue by next year. A trade war between the US and China willsignificantly impact this revenue source.

  • [By Peter Graham]

    A long term performance chart shows shares of large cap dollar stores Dollar Tree and Dollar General Corp (NYSE: DG) both outperforming Wal-Mart Stores, Inc (NYSE: WMT) and largely given investors roughly the same return:

  • [By Rich Smith]

    Third and finally, Plug’s move closer to Amazon is resulting in customer attrition among the company’s other customers, including Wal-Mart (NYSE:WMT), which may not want to patronize Plug products in the future, knowing that the company is so closely tied to (and may soon be part owned by) Amazon.

Top 10 Blue Chip Stocks To Buy Right Now: Staples, Inc.(SPLS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Staples, Inc. (NASDAQ: SPLS) got a boost, shooting up 7 percent to $9.25 on chatter that the company is targeted for an acquisition. Sycamore Partners, a private equity giant, is reportedly in advanced talks to acquire the office supply retailer, Reuters reported. The deal could value Staples at more than $6 billion, a premium to Staples' valuation of $5.60 billion as of Wednesday's market close.

  • [By Casey Wilson]

    The company was set to merge with its last remaining rival, Staples Inc. (Nasdaq: SPLS), this year, but was denied by a federal judge on May 10 because of antitrust concerns.

  • [By Jeremy Bowman]

    Staples Inc(NASDAQ:SPLS) stock has been on a tear over the last few days amid rumors of a potential buyout.According toThe Wall Street Journal, the company is in talks with private-equity firms to sell itself after regulators blew up its planned merger withOffice Depot(NASDAQ:ODP)last year.

  • [By Ben Levisohn]

    Staples (SPLS) soared to the top of the S&P 500 today on reports that the office-supplies retailer was considering selling itself.

    Agence France-Presse/Getty Images

    Staples gained 9.8% to $9.51 today, while the S&P 500 ticked up 0.1% to 2,360.16.

    CFRA’s Efraim Levy doesn’t see a “natural buyer” for Staples but remain Buy rated anyway:

    Shares are higher on an unconfirmed WSJ report that SPLS is looking at the possible sale of the company. Our fundamentally valued 12-month target of $11, applies a below historical average P/E of 12.1X our FY 18 EPS estimate, given office industry challenges. Our target has 11% upside, plus a 5.5% yield. We don’t see a natural buyer for a large physical store office supply presence, although an activist/private-equity buyer is a possibility. To make an acquisition worthwhile, a buyer would have to be more aggressive in cost cutting and use of cash flow than SPLS’s existing plan.

    Staples’ market capitalization rose to $6.2 billion today from $5.7 billion yesterday. It reported a net loss of $459 million on sales of $18.2 billion in fiscal 2017.

Top 10 Blue Chip Stocks To Buy Right Now: Merck & Company, Inc.(MRK)

Advisors’ Opinion:

  • [By William Romov]

    BioLine has partnerships with major pharmaceutical companies that help bring some of these drugs to launch once they gain some initial success in clinical trials. These partners include Novartis AG (NYSE: NVS) and Merck & Co. Inc. (NYSE: MRK).

  • [By Paul Ausick]

    Merck & Co. Inc. (NYSE: MRK) dropped about 2.9% Monday to post a new 52-week low of $53.63 after closing at $55.02 on Friday. The 52-week high is $66.80. Volume was around 12.7 million, more than 25% above the daily average of about 10 million. The company’s chief competitor in a combo therapy for lung cancer reported a successful phase 3 trial.

  • [By The Ticker Tape]

    LLY recently suffered a setback when approval for the company’s new arthritis drug, co-developed with Incyte Corporation (NASDAQ: INCY), faced delays from the FDA. LLY and INCY disagreed with the FDA’s findings in a company press release and are confident the drug will still be approved in the future. Despite the company’s confidence in the drug, LLY stock dropped about 5% in trading the day the news came out. Even with that drop, it’s still up a little over 11% on the year, outperforming the S&P 500 (SPX) and some of its pharma peers: Merck & Co., Inc. (NYSE: MRK), Pfizer Inc. (NYSE: PFE), and Johnson & Johnson (NYSE: JNJ).

  • [By Matthew Briar]

    Kudos to Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc. (NYSE:PFE) for taking a leap forward in the war against diabetes. The two competitors-turned-partners for one joint venture recently announced the FDA and the European equivalent has accepted an application for permission to sell ertugliflozin and a couple of its derivatives. All the drugs/combos in question are part of the SGLT2 family, which essentially induce the kidneys to filter sugar out of the bloodstream for diabetics whose pancreas isn’t processing that sugar properly.

    It’s an interesting approach, though not one without a potential downside. By forcing the kidneys to do something they weren’t meant to do, eventually, could pose new problems.

    Cell MedX Corp (OTCMKTS:CMXC) is taking an entirely different approach to the treatment of diabetes. Rather than work around a failing pancreas as Merck and Pfizer have, Cell MedX is aiming to fix what’s broken for diabetics. That is, the company aims to restore a body’s cells that properly process sugar by turning them back “on” again using mild electrical currents.

    As much as biologists and the healthcare industry know about the human body, new discoveries are being made all the time regarding our makeup. One of the more recent medical revelations was figuring out animals are not just a collection of chemicals and organic matter, but also electrical impulses. Yes, the human body creates electricity, but more than that, a body can benefit from mild electrical currents, as an electrical charge can put a damaged cell back into its natural, healthy state.

    It may seem like a crazy idea at first, but know the FDA has already given the science of electromedicine the nod of approval as a treatment for chronic pain (called the Cefaly, if you’re curious), and some major companies are wading deeper into electromedicine waters.

    As Scientific American’s Daisy Yuhas noted back in 2013:

Top 10 Blue Chip Stocks To Buy Right Now: Pain Therapeutics(PTIE)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

Top 10 Blue Chip Stocks To Buy Right Now: ZAIS Group Holdings, Inc.(ZAIS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 48 percent to $3.35. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 42 percent to $3.22. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus)
    Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha)
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
    ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
    Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30.
    Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
    Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19.
    Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
    TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25.
    Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
    CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.

Top 10 Blue Chip Stocks To Buy Right Now: Regal Entertainment Group(RGC)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Regal Entertainment Group (NYSE: RGC) was already rated as Underperform at Credit Suisse, but the firm said that the chain has weak trends and warned that its forecasts and multiples are just still too high. While raising some estimates, Sheikh lowered his target on Regal Entertainment to $17 from $19 in this call.

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to
  • [By Peter Graham]

    In December, UK based Cineworld Group Plc also agreed tobuy larger U.S. peer Regal Entertainment Group (NYSE: RGC) for $3.6 billion in cash in adeal to create the world’s second largest movie theatre operator after AMC Entertainment Holdings. The combined entity is expected to be better able to compete AMC.

Top 10 Blue Chip Stocks To Buy Right Now: Applied Micro Circuits Corporation(AMCC)

Advisors’ Opinion:

  • [By Piyush Arora]

    AMD, along with other server-grade chip manufacturers such as Qualcomm (NSDQ:QCOM), Cavium (NSDQ:CAVM) and AMCC (NSDQ:AMCC), operates in the remaining minuscule 0.8% of the market. So, each of the aforementioned companies operate with a practically non-existent market share, compared to Intels shipments of course. This also means that these firms (AMD, Qualcomm etc.) have plenty of room to grow. This would be subject to good product releases of course, but at least this way, the law of large numbers isnt working against them.

Top 10 Blue Chip Stocks To Buy Right Now: Great Basin Scientific, Inc.(GBSN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Great Basin Scientific Inc. (NASDAQ: GBSN) dropped about 15% on Thursday to post a new 52-week low of $2.90 after closing at $3.42 on Wednesday. The stock’s 52-week high is $45,024.00. Volume was more than 3 times the daily average of around 150,000 shares. The medical diagnostics company had no specific news Thursday. Since mid-March the company has split the stock twice: the first was a 1-for-35 split and the second a 1-for-80 split.

  • [By Lisa Levin]

    Great Basin Scientific Inc (NASDAQ: GBSN) shares dropped 18 percent to $0.92 on Q1 results. Great Basin Scientific posted Q1 net income of $21,503,600, versus a year-ago net loss of $33,652,500.

Top 10 Blue Chip Stocks To Buy Right Now: Safeway Inc.(SWY)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap SUPERVALU now underperforming large cap Kroger Co (NYSE: KR) while shares of large cap Whole Foods Market, Inc (NASDAQ: WFM) and mid cap Safeway Inc (NYSE: SWY) appear to be back to where they started at:

  • [By Peter Graham]

    A long term performance chart shows shares of SUPERVALU underperforming the underperformance ofmid caps Whole Foods Market, Inc (NASDAQ: WFM) and Safeway Inc (NYSE: SWY). while large capKroger Co (NYSE: KR)had outperformed up until the last two years when performance has been more mixed:

stocks to invest in today

U.S. equities drifted lower again on Friday as investors were spooked by comments from North Korea’s foreign minister that it considers President Trump’s Twitter taunts — “little rocket man” and all that — tantamount to a declaration of war. As a result, he claimed Pyongyang would take the initiative and reserve the right to attack American warplanes in international airspace.

The White House responded that this was absurd. But Trump himself has yet to comment on the matter.

All this, combined with a referendum vote in Northern Iraq on independence (with the threat of a military intervention by Baghdad) weighed on sentiment with large-cap technology stocks hit hardest on frothy valuations.

In the end, the Dow Jones Industrial Average lost 0.2%, the S&P 500 gave back 0.2%, the Nasdaq Composite shed 0.9% and the Russell 2000 bucked the trend to gain 0.1%. Treasury bonds strengthened on a safe haven bid, the dollar lagged, gold gained 1.3% and crude oil fell 3.1% on fears the Kurdish vote in Iraq could result in political destabilization and thus weigh on output.

stocks to invest in today: Pain Therapeutics(PTIE)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

stocks to invest in today: Callidus Software, Inc.(CALD)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, technology shares fell 0.14 percent. Meanwhile, top losers in the sector included Sequans Communications SA ADR (NYSE: SQNS), down 8 percent, and Callidus Software Inc. (NASDAQ: CALD), down 6 percent.

stocks to invest in today: Navios Maritime Holdings Inc.(NM)

Advisors’ Opinion:

  • [By Monica Gerson]

    Navios Maritime Holdings Inc. (NYSE: NM) is expected to report a quarterly loss at $0.37 per share on revenue of $101.51 million.

    Pure Storage Inc (NYSE: PSTG) is estimated to post a quarterly loss at $0.23 per share on revenue of $138.13 million.

  • [By Nickey Friedman]

    Navios Maritime Holdings (NYSE: NM  ) has two operating segments: shipping and logistics. Analysts have already begun to raise their profit estimates for 2014, currently at $0.11 EPS up from $0.01 a week ago. Expect that number to continue to rise dramatically. Navios pays a $0.06 per share quarterly dividend and trades around 40% below its book value. It used to trade as high as $17 back in 2007.

stocks to invest in today: Telefonica Brasil S.A.(VIV)

Advisors’ Opinion:

  • [By Sofia Horta e Costa]

    Vivendi (VIV) rose 2.7 percent to 17.15 euros. Music, pay-TV, European cinema and Internet in Brazil will make up a new media group based in France after the split with phone unit SFR, according to a statement yesterday.

  • [By Lisa Levin]

    In trading on Wednesday, telecommunications services shares slipped by 0.08 percent. Meanwhile, top losers in the sector included Turkcell Iletisim Hizmetleri A.S. (ADR) (NYSE: TKC), down 2 percent, and Telefonica Brasil SA (ADR) (NYSE: VIV), down 2.5 percent.

stocks to invest in today: 2U, Inc.(TWOU)

Advisors’ Opinion:

  • [By David Kretzmann]

    Since its IPO in March 2014, 2U (NASDAQ:TWOU) stock is up over 160% as the company forges partnerships with famous schools, including Georgetown, Yale, Berkeley, and New York University.